IDO2 and breast carcinoma: Our result showed that IDO1, IDO2 and HLA-G5 had higher mRNA expressionsin ASCs isolated from breast cancer patients than those from normal individuals (P>0.05).mRNA expression of these molecules were higher in ASCs isolated from breast cancerpatients with stage III tumors than those with stage II.